Singapore General Hospital, Department of Plastic, Reconstructive and Aesthetic Surgery, 20 College Road, Academia Level 4, Singapore, 169845 Singapore ; Singapore General Hospital, Skin Bank Unit, Block 4 Level 3 Room 15, Outram Road, Singapore, 169608 Singapore ; Transplant Tissue Centre, c/o Skin Bank Unit, Singapore General Hospital, Block 4 Level 3 Room A7, Outram Road, Singapore, 169608 Singapore.
Singapore General Hospital, Skin Bank Unit, Block 4 Level 3 Room 15, Outram Road, Singapore, 169608 Singapore ; Transplant Tissue Centre, c/o Skin Bank Unit, Singapore General Hospital, Block 4 Level 3 Room A7, Outram Road, Singapore, 169608 Singapore.
Burns Trauma. 2016 Feb 19;4:3. doi: 10.1186/s41038-016-0027-y. eCollection 2016.
Current advances in basic stem cell research and tissue engineering augur well for the development of improved cultured skin tissue substitutes: a class of products that is still fraught with limitations for clinical use. Although the ability to grow autologous keratinocytes in-vitro from a small skin biopsy into sheets of stratified epithelium (within 3 to 4 weeks) helped alleviate the problem of insufficient donor site for extensive burn, many burn units still have to grapple with insufficient skin allografts which are used as intermediate wound coverage after burn excision. Alternatives offered by tissue-engineered skin dermal replacements to meet emergency demand have been used fairly successfully. Despite the availability of these commercial products, they all suffer from the same problems of extremely high cost, sub-normal skin microstructure and inconsistent engraftment, especially in full thickness burns. Clinical practice for severe burn treatment has since evolved to incorporate these tissue-engineered skin substitutes, usually as an adjunct to speed up epithelization for wound closure and/or to improve quality of life by improving the functional and cosmetic results long-term. This review seeks to bring the reader through the beginnings of skin tissue engineering, the utilization of some of the key products developed for the treatment of severe burns and the hope of harnessing stem cells to improve on current practice.
这一类产品在临床应用中仍然存在诸多限制。尽管能够从小面积皮肤活检中体外培养自体角质细胞成层状上皮片(3 到 4 周内)有助于缓解大面积烧伤供体部位不足的问题,但许多烧伤单位仍不得不应对异体移植物不足的问题,这些异体移植物被用作烧伤切除后的中间创面覆盖物。组织工程皮肤真皮替代品可满足紧急需求的替代品已被相当成功地应用。尽管这些商业产品已经存在,但它们都存在相同的问题,即成本极高、皮肤微观结构不正常和植入不一致,尤其是在全层烧伤中。严重烧伤治疗的临床实践已经发展到将这些组织工程皮肤替代品纳入其中,通常作为加速创面闭合的上皮化的辅助手段,或通过改善长期的功能和美容效果来提高生活质量。本综述旨在引导读者了解皮肤组织工程的起源、一些用于治疗严重烧伤的关键产品的应用以及利用干细胞来改进现有实践的希望。